The emerging role of speckle-type POZ protein (SPOP) in cancer development
- 21 July 2014
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 19 (9), 1498-1502
- https://doi.org/10.1016/j.drudis.2014.07.009
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney CancerCancer Cell, 2014
- Destruction of Full-Length Androgen Receptor by Wild-Type SPOP, but Not Prostate-Cancer-Associated MutantsCell Reports, 2014
- Speckle-type POZ protein, SPOP, is involved in the DNA damage responseCarcinogenesis: Integrative Cancer Research, 2014
- SPOP Mutations in Prostate Cancer across Demographically Diverse Patient CohortsNeoplasia, 2014
- The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligaseNature, 2003
- MacroH2A1.2 binds the nuclear protein SpopBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2002
- A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor DomainsJournal of Biological Chemistry, 2001
- Gene Amplification and Expression of the Steroid Receptor Coactivator SRC3 (AIB1) in Sporadic Breast and Endometrial CarcinomasHormone and Metabolic Research, 2001
- The ubiquitin systemNature Medicine, 2000
- EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genesOncogene, 2000